Position in KYMR
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,266,530
+$363,250 QoQ
Shares Held
11,045
+1.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#144
of 275 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,501,972 across 8 Biotechnology names. KYMR ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
This page
|
11,045 | $1,266,530 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,184 | $1,084,858 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
909 | $566,797 | |
| 4 | INCY |
Incyte Corp
|
4,483 | $508,192 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,786 | $430,372 | |
| 6 | MRNA |
Moderna, Inc.
|
4,251 | $297,697 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
919 | $276,646 | |
| 8 | FATE |
Fate Therapeutics Inc
|
26,252 | $70,880 |
All Filings in KYMR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,266,530 | 11,045 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $903,280 | 10,845 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $843,849 | 10,845 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $396,200 | 7,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $305,480 | 7,000 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||